Open access
Aug 2026
Comparative immunogenicity of mRNA-1273 and BNT162b2 SARS-CoV-2 bivalent booster vaccines in US nursing home residents
ABSTRACT Nursing home residents (NHRs) remain among the most vulnerable to severe outcomes from SARS-CoV-2 infection. While mRNA-1273 (Spikevax, Moderna) and BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccines are widely used in this population, comparative data on their immunogenicity, particularly after bivalent boosters,...
Olajide J. Olagunju, Oladayo A. Oyebanji, Debbie Keresztesy et al.
· Human Vaccines & Immunothera... · 0 citations